Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $758K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
ANI Pharmaceuticals USD 4.41M 316K Dec/2025
Assertio Holdings USD 758K 1000 Jun/2024
Aurora Cannabis CAD 2.11M 116K Dec/2025
Cara Therapeutics 39.02M 4.73M Sep/2025
Daiichi Sankyo JPY 2.16B 1.33B Dec/2025
Ironwood Pharmaceuticals USD 8.74M 506K Dec/2024
J&J USD 18M 290M Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Merck USD 412M 85M Dec/2025
Nektar Therapeutics USD 9.77M 3.75M Dec/2025
Omeros USD 4.05M 5.16M Sep/2024
Pfizer USD 711M 59M Dec/2025
Teva Pharmaceutical Industries USD 220M 17M Dec/2025